drugset
drugset / Trial / NCT03298815

Study for the Treatment of Ocular Chronic Graft-Versus-Host Disease (GVHD) With Amniotic Fluid Eye Drops (AFED)

NCT03298815 ↗

Phase 1/2 Completed 15 enrolled University of Utah
RandomizedParallel-groupDouble-blindTreatment

Summary

A Randomized, Double-blinded, Placebo-Controlled Study for the Treatment of Ocular Chronic Graft Verses Host Disease with Processed Amniotic Fluid (pAF) Drops.

Timeline

Start
2019-12-20
Primary completion
2022-12-16
Completion
2023-02-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Processed Amniotic Fluid Unknown 0.25 ml Topical

Indications

chronic graft versus host disease